Avanir Pharmaceuticals Inc (NASDAQ:AVNR) Investor Alert: Lawsuit Against Takeover Filed
An investor, who currently holds shares of Avanir Pharmaceuticals Inc (NASDAQ:AVNR filed a lawsuit in effort to halt the proposed takeover of Avanir Pharmaceuticals Inc by Otsuka Pharmaceutical Co for $17.00 per share.
View full press release